Arcutis Biotherapeutics Inc Cash Flow Reinvestment Rate

Latest as of June 2026: 1.20x

Arcutis Biotherapeutics Inc cash flow reinvestment rate. Arcutis Biotherapeutics Inc (ARQT) has a Cash Flow Reinvestment Rate of 1.20x as of June 2026, reinvesting $15.22 Million (capex $158.00K plus investments $-15.07 Million) from operating cash flow of $12.64 Million. See Arcutis Biotherapeutics Inc (ARQT) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.20x
(Capex + Investments) / Operating CF

Total Reinvested

$15.22 Million
Capex + Investments

Operating Cash Flow

$12.64 Million
USD

Capital Expenditures

$158.00K
USD

Arcutis Biotherapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)

Arcutis Biotherapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Arcutis Biotherapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Arcutis Biotherapeutics Inc generate cash.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow